All Stories

  1. The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress

    Article • Current Neuropharmacology, August 2021, Bentham Science Publishers

    Peter Calverley, Professor Hartmut Jaeschke

  2. Oscillometry: old physiology with a bright future

    Article • European Respiratory Journal, September 2020, European Respiratory Society (ERS)

    Peter Calverley

  3. Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2019, Taylor & Francis

    Peter Calverley, Mario Cazzola, Dr Arrigo FG CICERO, edoardo pozzi

  4. Genetics, Chronic Obstructive Pulmonary Disease, and the Arrow of Time

    Article • American Journal of Respiratory and Critical Care Medicine, September 2019, American Thoracic Society

    Peter Calverley

  5. Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, April 2018, Dove Medical Press

    Peter Calverley, Achim Mueller, Robert Wise

  6. Use of a 4-week up-titration regimen of roflumilast in patients with severe COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, March 2018, Dove Medical Press

    Professor Klaus F. Rabe, Peter Calverley

  7. The Effect of Defining Chronic Obstructive Pulmonary Disease by the Lower Limit of Normal of FEV1/FVC Ratio in Tiotropium Safety and Performance in Respimat Participants

    Article • Annals of the American Thoracic Society, February 2018, American Thoracic Society

    Peter Calverley

  8. Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR® trial

    Article • International Journal of Chronic Obstructive Pulmonary Disease, February 2018, Dove Medical Press

    Peter Calverley, Robert Wise

  9. Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk

    Article • American Review of Respiratory Disease, January 2018, American Thoracic Society

    Peter Calverley

  10. Eosinophilia, Frequent Exacerbations, and Steroid Response in Chronic Obstructive Pulmonary Disease

    Article • American Review of Respiratory Disease, November 2017, American Thoracic Society

    Peter Calverley

  11. Determinants of exacerbation risk in patients with COPD in the TIOSPIR study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, November 2017, Dove Medical Press

    Peter Calverley, Achim Mueller, Kay Tetzlaff, Robert Wise

  12. Breathlessness despite optimal pathophysiological treatment: on the relevance of being chronic

    Article • European Respiratory Journal, September 2017, European Respiratory Society (ERS)

    Peter Calverley

  13. The association of tidal EFL with exercise performance, exacerbations, and death in COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, July 2017, Dove Medical Press

    Peter Calverley, Raffaele Dellaca'

  14. The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials

    Article • International Journal of Chronic Obstructive Pulmonary Disease, May 2017, Dove Medical Press

    Dr Göran Eriksson, Peter Calverley

  15. AJRCCM: 100-Year Anniversary.Physiology and Chronic Obstructive Pulmonary Disease in the Blue Journals

    Article • American Review of Respiratory Disease, May 2017, American Thoracic Society

    Peter Calverley

  16. Chronic breathlessness: symptom or syndrome?

    Article • European Respiratory Journal, May 2017, European Respiratory Society (ERS)

    Peter Calverley

  17. Through a glass darkly: inhaled corticosteroids, airway inflammation and COPD

    Article • European Respiratory Journal, January 2017, European Respiratory Society (ERS)

    Peter Calverley

  18. Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2016, Dove Medical Press

    Dr Göran Eriksson, Peter Calverley

  19. Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations

    Article • International Journal of Chronic Obstructive Pulmonary Disease, February 2016, Dove Medical Press

    Dr Göran Eriksson, Peter Calverley

  20. Roflumilast: a review of its use in the treatment of COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, January 2016, Dove Medical Press

    Professor Klaus F. Rabe, Peter Calverley

  21. Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR® trial

    Article • International Journal of Chronic Obstructive Pulmonary Disease, January 2016, Dove Medical Press

    Peter Calverley, Robert Wise

  22. Knowing when to stop: inhaled corticosteroids and COPD

    Article • European Respiratory Journal, October 2015, European Respiratory Society (ERS)

    Peter Calverley

  23. New Pharmacotherapeutic Approaches for Chronic Obstructive Pulmonary Disease

    Article • Seminars in Respiratory and Critical Care Medicine, August 2015, Thieme Publishing Group

    Peter Calverley

  24. Large trials, new knowledge: the changing face of COPD management

    Article • European Respiratory Journal, March 2015, European Respiratory Society (ERS)

    Peter Calverley

  25. A score to predict short-term risk of COPD exacerbations (SCOPEX)

    Article • International Journal of Chronic Obstructive Pulmonary Disease, January 2015, Taylor & Francis

    Dr Göran Eriksson, Peter Calverley

  26. Roflumilast and dyspnea in patients with moderate to very severe chronic obstructive pulmonary disease: a pooled analysis of four clinical trials

    Article • International Journal of Chronic Obstructive Pulmonary Disease, June 2014, Taylor & Francis

    Peter Calverley

  27. Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? the REACT study protocol

    Article • International Journal of Chronic Obstructive Pulmonary Disease, June 2012, Taylor & Francis

    Peter Calverley

  28. Chronic airflow limitation in a rural Indian population: etiology and relationship to body mass index

    Article • International Journal of Chronic Obstructive Pulmonary Disease, October 2011, Taylor & Francis

    Peter Calverley, Biswajit Chakrabarti